BGMS
NASDAQ · Biotechnology
Bio Green Med Solution Inc
$0.90
-0.02 (-1.79%)
Open$0.95
Previous Close$0.92
Day High$0.95
Day Low$0.88
52W High$6.70
52W Low$0.57
Volume—
Avg Volume341.7K
Market Cap6.17M
P/E Ratio—
EPS$-0.76
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+740.1% upside
Current
$0.90
$0.90
Target
$7.59
$7.59
$6.77
$7.59 avg
$11.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.26M | 1.16M | 1.19M |
| Net Income | -9,076,727 | -117,803 | -121,826 |
| Profit Margin | -401.3% | -10.2% | -10.2% |
| EBITDA | -10,520,932 | -246,829 | -223,977 |
| Free Cash Flow | — | -166,595 | -168,575 |
| Rev Growth | — | +16.9% | +20.6% |
| Debt/Equity | — | 0.36 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |